Using antigenic cartography, researchers analyzed cross-reactivity patterns of SARS-CoV-2 variants and the effect of spike-protein changes on post-infection and vaccination immune responses. The study illuminated unique neutralization profiles and underscored the evolving defense mechanisms with repeated immunizations.
GSK pulls plans to market anemia drug in EU and other markets, citing ‘reduced opportunity’
It appears GSK’s Jesduvroq will not launch in new markets for now, with the pharma giant withdrawing its bid to market the anemia drug in